Drug Development Drugs Pharma Companies White Paper 
PerkinElmer
FEBRUARY 18, 2021
Industry leaders reveal how high throughput screening is changing in R&D What do you think are the major trends in drug discovery R&D? That is not what PerkinElmer found in a comprehensive survey of leaders at the top 20 Pharma, ranked for R&D spending. A PerkinElmer White Paper offers a detailed look at the findings.
The Pharma Data
OCTOBER 16, 2020
As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. Download Medidata’s white paper to learn how to virtualize clinical trials and bring new therapies closer to patients.
Expert insights. Personalized for you.
52 
Let's personalize your content